San Francisco, CA /PRNewswire/ - Fulcrum, a leading field inspection management platform, has integrated Esri's ArcGIS Maps software development kit (SDK) into its platform to provide customers with ...
Fulcrum granted the new employees 30,400 options to purchase shares of the company’s common stock at an exercise price of $10 ...
Fulcrum Therapeutics’ sickle cell disease therapy has been placed on a clinical hold by the FDA, capping off a tough week for drug development for the condition that saw three separate treatments ...
Fulcrum Therapeutics thinks it has “proof of biology” for an early-stage sickle cell disease treatment, a result that has offered a bit of optimism several weeks after the biotech announced the ...
A live webcast of the presentation will be accessible HERE or by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations.
CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve ...
Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.
TORONTO--(BUSINESS WIRE)--Fulcrum IT Partners ("Fulcrum") announces the successful acquisition of F3 Technology Partners (“F3”), marking the company's second U.S. acquisition and fourth global ...
CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically ...
A Fulcrum Therapeutics clinical trial testing a potential sickle cell disease drug has been paused by the FDA. With the clinical hold on the early-stage study, Fulcrum becomes the fourth company this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback